Drug intelligence / Profile preview

olaflur

Development stage
Unknown
Lead developer
GABA International
Modality
Small Molecules
Administration
Topical
01

Overview

Olaflur is a small molecule, also known as amine fluoride 297, used primarily as a topical fluoride treatment to prevent dental caries (tooth decay), treat sensitive teeth, and aid in the refluoridation of damaged tooth enamel. It is commonly found as an ingredient in toothpastes and dental gels—most notably under the brand name "elmex gel"—and has been in use since 1966. Olaflur consists of an alkyl ammonium cation with a long lipophilic hydrocarbon chain (giving it surfactant properties) and a fluoride counterion. Its mechanism involves forming a film on the surface of teeth that facilitates incorporation of fluoride into enamel; this process converts hydroxylapatite (the primary mineral in enamel) into more robust fluorapatite, thereby strengthening the enamel and reducing susceptibility to caries. The depth of fluoridation is limited to only a few nanometers. Olaflur is often used alone or combined with other fluorides such as dectaflur for enhanced effect[1][2][3][4][6].

Brand names
elmex gel
Other names
olafluramine fluoride 297

Beyond the preview

Go deeper on olaflur.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on olaflur.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call